Myomo (MYO) Non Operating Investment Income (2017 - 2023)
Myomo (MYO) reported Non Operating Investment Income of -$70124.0 for Q3 2023, down 321.11% on a YoY basis from $31713.9 in Q3 2022, and down 460.36% quarter-over-quarter from -$12514.0 in Q2 2023.
Myomo (MYO) Non Operating Investment Income (2017 - 2023) Analysis & Trends
Myomo has reported Non Operating Investment Income for 6 years, with the latest figure at -$70124.0 in Q3 2023.
- For the quarter ending Q3 2023, Non Operating Investment Income fell 321.11% year-over-year to -$70124.0; the trailing twelve-month figure through Sep 2023 stood at -$132498.0 (down 170.56% YoY), and the FY2020 full-year result was $122706.0, down 36.91% from the prior year.
- Non Operating Investment Income for Q3 2023 stood at -$70124.0, down from -$12514.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $99449.0 in Q2 2019, with the low at -$70124.0 in Q3 2023.
- Historically, Non Operating Investment Income has averaged $16790.3 across 4 years, with a median of $14536.0 in 2019.
- Annual changes were most pronounced in 2019 — Non Operating Investment Income soared 3637.28% — and 2023, when it tumbled 321.11%.
- Myomo's Non Operating Investment Income stood at $38530.0 in 2019, then tumbled by 97.7% to $888.0 in 2020, then tumbled by 1975.23% to -$16652.0 in 2022, then plunged by 321.11% to -$70124.0 in 2023.
- The last three Non Operating Investment Income figures came in at -$70124.0 (Q3 2023), -$12514.0 (Q2 2023), and -$16652.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Myomo | 45.01 Mn | 26.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -70,124.00 |
| Sep 30, 2023 | -70,124.00 |
| Jun 30, 2023 | -12,514.00 |
| Jun 30, 2023 | -12,514.00 |
| Sep 30, 2022 | -16,652.00 |
| Sep 30, 2022 | -16,652.00 |
| Jun 30, 2022 | -33,208.00 |
| Jun 30, 2022 | -33,208.00 |
| Sep 30, 2020 | 888.00 |
| Sep 30, 2020 | 888.00 |
| Jun 30, 2020 | 39,717.00 |
| Jun 30, 2020 | 39,717.00 |
| Mar 31, 2020 | 82,101.00 |
| Mar 31, 2020 | 82,101.00 |
| Dec 31, 2019 | 38,530.00 |
| Dec 31, 2019 | 38,530.00 |
| Sep 30, 2019 | 14,536.00 |
| Sep 30, 2019 | 14,536.00 |
| Jun 30, 2019 | 99,449.00 |
| Jun 30, 2019 | 99,449.00 |